Number of Previous Cesarean Sections on the Results of Angiogenic Factors.
Effect of Number of Previous Cesarean Sections on the Results of Angiogenic Factors. A Descriptive, Prospective Study.
1 other identifier
observational
540
1 country
1
Brief Summary
Hypertensive disorders of pregnancy (HPT) are an important cause of maternal-feto-neonatal morbidity and mortality, being one of the three leading causes of maternal death in our country and in developing countries. The only cure for THE is termination of pregnancy, which ends up being a decision in which gestational age and maternal risks must be balanced. Angiogenic factors have come to occupy an indispensable place in the arsenal of tools that can be used to separate the patient with a high likelihood of complications from those in whom prolongation of pregnancy could represent an important neonatal benefit. Although the usefulness of angiogenic factors in these scenarios is known, little is known about the effects that other conditions might have on their serum levels, mainly those that have an effect on trophoblastic invasion, the process that initiates implantation of the pregnancy in the endometrium. The purpose of the present study is to assess the effect that a history of uterine surgery, such as caesarean section, might have on angiogenic factor scores in subjects with no history of a hypertensive disorder of pregnancy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2023
CompletedFirst Posted
Study publicly available on registry
December 12, 2023
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 30, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2026
CompletedAugust 26, 2025
August 1, 2025
4 months
December 4, 2023
August 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Index sFlt-1/PIGF
Angiogenic factors, normal value.
From the moment of randomization up until delivery. Between 24-48 hours.
Secondary Outcomes (1)
Progression to preeclampsia
Up until discharge. On average, 7 days
Study Arms (2)
Previous Cesarean Section
Subjects with one or more previous cesarean sections
No Cesarean
Subjects scheduled for an elective or urgent cesarean, but no history of previous cesarean section
Interventions
Eligibility Criteria
Pregnant woman with a previous cesarean section
You may qualify if:
- weeks of gestation or more
- Singleton pregnancy
- Previous cesarean section (case)
You may not qualify if:
- Vasculitis
- Twin pregnancy
- Chronic endometritis
- Smoking
- Lupus
- Renal failure
- Liver disease
- Thrombocytopenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saint Thomas H
Panama City, Provincia de Panamá, Panama
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Osvaldo Reyes
Hospital Santo Tomás
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of the research deparment
Study Record Dates
First Submitted
December 4, 2023
First Posted
December 12, 2023
Study Start
October 1, 2025
Primary Completion
January 30, 2026
Study Completion
March 30, 2026
Last Updated
August 26, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share